(Q71059806)
Statements
Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients (English)
P Nygren
M Sandström
A Freijs
M L Fjällskog
J Bergh